• We are a biotech company in
    infectious diseases with
    two marketed products.

  • Dedicated to innovation in
    vaccine research & development.

  • Valneva covers the full
    value chain from bench
    to market.

Welcome to Valneva

Joining forces to create a European biotech leader in vaccines


— May 12, 2015

Valneva Reports Strong Q1 2015 Financial Results and Provides Operational Update
Read more

— Stock information



—News, Mar.17, 2015

Signing of an exclusive license agreement on EB66® Cell Line in China

 Read more

— Financial calendar


June 25, 2015

Annual General Meeting

All dates     


– Upcoming conferences and fairs

May 24 - 28, 2015
CISTM14 – 14th conference of the International Society of Travel Medicine
Québec City, Canada

June 15 - 18, 2015
Bio International Convention
Philadelphia, United States

Meet our Business Development team

European pure vaccine player with international footprint.

Please update your browser...